Effects on striatal and mesolimbic dopamine systems of a new potential antipsychotic drug -mezilamine- with weak cataleptogenic properties
- 30 June 1978
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 23 (3), 261-273
- https://doi.org/10.1016/0024-3205(78)90314-4
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Correlation between neuroleptic-induced suppression of stereotyped behaviour and HVA concentrations in rat brainJournal of Pharmacy and Pharmacology, 1976
- Antipsychotic Drugs: Direct Correlation Between Clinical Potency and Presynaptic Action on Dopamine NeuronsScience, 1975
- Thioridazine: Central dopamine turnover and clinical effects of antipsychotic drugsClinical Pharmacology & Therapeutics, 1975
- Effect of single and repeated administration of clozapine on the metabolism of dopamine and noradrenaline in the brain of the ratEuropean Journal of Pharmacology, 1974
- Drugs, Neurotransmitters, and SchizophreniaScience, 1974
- DOPAMINE IN THE MESOLIMBIC SYSTEM OF THE RAT BRAIN: ENDOGENOUS LEVELS AND THE EFFECTS OF DRUGS ON THE UPTAKE MECHANISM AND STIMULATION OF ADENYLATE CYCLASE ACTIVITYJournal of Neurochemistry, 1974
- An Anatomy of Schizophrenia?Archives of General Psychiatry, 1973
- Effect of clozapine on the turnover of dopamine in the corpus striatum and in the limbic systemJournal of Pharmacy and Pharmacology, 1973
- REGIONAL STUDIES OF CATECHOLAMINES IN THE RAT BRAIN‐IJournal of Neurochemistry, 1966
- On the occurrence of homovanillic acid in brain and cerebrospinal fluid and its determination by a fluorometric methodLife Sciences, 1963